News
Boston Scientific Corporation (NYSE: BSX) today announced positive 12-month primary endpoint results from the second phase of ...
Context for Practice: Cancer-Related Wounds, Cost of Living With a New Fecal Ostomy, Intermittent Catheterization Education, and Innovation in Catheter Design.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback